Analgesics Market Analysis and Forecast to 2022 by Recent Trends, Developments in Manufacturing Technology and Regional Growth Overview

Analgesics, also known as painkillers, are used to treat and reduce pain in the body. Typically, they are used when the pain is severe and becomes unbearable for the patient. Non-opioids, opioids, and compound analgesics (a combination of both opioids and non-opioids) are the major analgesic products used globally. The emergence of analgesics is mainly attributed to the increase in acute and chronic diseases, as well as the rising incidence of cancer worldwide.

Opioid drugs are the strongest types of analgesics, which are derived from opium. They are chiefly used for the treatment of moderate to severe pain and are mostly available through prescription. On the other hand, non-opioid drugs are not derived from opium but include acetaminophen. They also include non-steroidal anti-inflammatory drugs (NSAIDs) and are majorly used for the treatment of mild to moderate pain. In addition, non-opioid drugs are sometimes used alongside stronger painkillers. They are mostly available over-the-counter (OTC); however, some NSAIDs, such as Celebrex, Cataflam, and Motrin, are available through prescription only.

Analgesics Market Segment by Manufacturers:

Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi.

Get Sample Copy of this Report at https://www.reportsweb.com/inquiry&RW00012660179/sample

The world analgesics market is expected to achieve moderate growth in the near future, majorly because of factors such as increase in cardiovascular disease, cancer, and arthritis and growing geriatric population. Recurring pain and aches experienced by the ageing population is another factor the helps the market growth. In addition, increasing investments in R&D by the public and private sector, with key emphasis on the classes of compounds for formulating new therapeutics, are further expected to drive the market. However, factors such as uncontrolled prescription of opioids, drug abuse, and unregulated government policies are likely to restrain the growth of the market.

Analgesics Market also analyses the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

This report studies Analgesics in Global market, especially in North America, Europe, Asia-Pacific, LAMEA.

Analgesics Market Segment by Type: Non-opioids, Opioids.

Analgesics Market Segment by Route of Administration: Oral, Intravenous, Rectal, Transdermal, Topical.

Get discount on Purchase report at https://www.reportsweb.com/inquiry&RW00012660179/discount

KEY BENEFITS FOR STAKEHOLDERS:

This report includes a detailed quantitative analysis of the current market trends and estimations from 2015 to 2022, which assists in identifying the prevailing market opportunities.

Geographically, the analgesics market is analyzed based on key regions such as North America, Europe, Asia-Pacific, andLAMEA.

This study evaluates the competitive landscape of the analgesics market to aid the reader in understanding the competitive environment across the geographic locations.

Furthermore, key market players within this market have been profiled in this report and their strategies are analyzed thoroughly. This helps in understanding the competitive outlook on the supply side of the market.

Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 MARKET OVERVIEW

CHAPTER 4 WORLD Analgesics MARKET BY TYPE

CHAPTER 5 GLOBAL Analgesics MARKET BY END USER

CHAPTER 6 GLOBAL Analgesics MARKET BY GEOGRAPHY

CHAPTER 7 COMPANY PROFILE

Purchase a Copy of Report at https://www.reportsweb.com/buy&RW00012660179/buy/4999

Contact Us

Phone : +1-646-491-9876

E-Mail : [email protected]

Posted by on Tuesday June 25 2019, 12:02 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Diagnostics, Healthcare, Life Sciences, Medical Devices. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in